OTCPK:TRSBF (China)
Â
Shs Unitary 144A/Reg S
$
0.83
(0%)
07:08 PM EST
What is a stock summary page? Click here for an overview.
Business Description
3SBio Inc
ISIN : KYG8875G1029
Share Class Description:
TRSBF: Shs Unitary 144A/Reg SCompare
Compare
Traded in other countries / regions
01530.Hong Kong83B.GermanyTRSBF.USA IPO Date
2018-06-15Description
3SBio Inc is a biotechnology company. As a pioneer in the Chinese biotechnology industry, the Group has extensive expertise in researching, developing, manufacturing, and marketing biopharmaceuticals. The core products of the Group include several biopharmaceutical drugs, TPIAO recombinant human erythropoietin rhEPO products EPIAO and SEPO, Yisaipu, Cipterbin, and a small molecule drug, Mandi. Except for minoxidil, an over-the-counter drug, the others are all older-generation biologics.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.63 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.23 | |||||
| Debt-to-EBITDA | 1.22 | |||||
| Interest Coverage | 14.33 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 3.66 | |||||
| Beneish M-Score | -2.35 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.3 | |||||
| 3-Year EBITDA Growth Rate | 22.7 | |||||
| 3-Year EPS without NRI Growth Rate | 19.8 | |||||
| 3-Year FCF Growth Rate | 58.2 | |||||
| 3-Year Book Growth Rate | 8.7 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 10.68 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 99.99 | |||||
| 14-Day RSI | 99.75 | |||||
| 6-1 Month Momentum % | 14.49 | |||||
| 12-1 Month Momentum % | 3.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.71 | |||||
| Quick Ratio | 1.57 | |||||
| Cash Ratio | 1.06 | |||||
| Days Inventory | 229.24 | |||||
| Days Sales Outstanding | 46.53 | |||||
| Days Payable | 57.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Payout Ratio | 0.24 | |||||
| 3-Year Average Share Buyback Ratio | 1.9 | |||||
| Shareholder Yield % | 4.38 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 85.95 | |||||
| Operating Margin % | 30.05 | |||||
| Net Margin % | 22.96 | |||||
| FCF Margin % | 14.36 | |||||
| ROE % | 14.21 | |||||
| ROA % | 8.68 | |||||
| ROIC % | 12.36 | |||||
| 3-Year ROIIC % | 17.08 | |||||
| ROC (Joel Greenblatt) % | 51.07 | |||||
| ROCE % | 15.14 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.17 | |||||
| Forward PE Ratio | 6.37 | |||||
| PE Ratio without NRI | 11.58 | |||||
| Shiller PE Ratio | 23.69 | |||||
| Price-to-Owner-Earnings | 21.9 | |||||
| PEG Ratio | 1.08 | |||||
| PS Ratio | 3.03 | |||||
| PB Ratio | 1.82 | |||||
| Price-to-Tangible-Book | 2.96 | |||||
| Price-to-Free-Cash-Flow | 20.8 | |||||
| Price-to-Operating-Cash-Flow | 13.53 | |||||
| EV-to-EBIT | 8.36 | |||||
| EV-to-Forward-EBIT | 4.54 | |||||
| EV-to-EBITDA | 8.36 | |||||
| EV-to-Forward-EBITDA | 5.07 | |||||
| EV-to-Revenue | 2.67 | |||||
| EV-to-Forward-Revenue | 1.2 | |||||
| EV-to-FCF | 18.56 | |||||
| Price-to-GF-Value | 1.15 | |||||
| Price-to-Projected-FCF | 1.08 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.43 | |||||
| Price-to-Graham-Number | 1.24 | |||||
| Price-to-Net-Current-Asset-Value | 41.4 | |||||
| Earnings Yield (Greenblatt) % | 11.96 | |||||
| FCF Yield % | 4.93 | |||||
| Forward Rate of Return (Yacktman) % | 14.01 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:TRSBF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
3SBio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,253.136 | ||
| EPS (TTM) ($) | 0.117 | ||
| Beta | -0.04 | ||
| 3-Year Sharpe Ratio | -0.25 | ||
| 3-Year Sortino Ratio | -0.52 | ||
| Volatility % | 17.19 | ||
| 14-Day RSI | 99.75 | ||
| 14-Day ATR ($) | 0.000058 | ||
| 20-Day SMA ($) | 0.8279 | ||
| 12-1 Month Momentum % | 3.49 | ||
| 52-Week Range ($) | 0.7231 - 0.8279 | ||
| Shares Outstanding (Mil) | 2,376.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
3SBio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
3SBio Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
3SBio Inc Frequently Asked Questions
What is 3SBio Inc(TRSBF)'s stock price today?
The current price of TRSBF is $0.83. The 52 week high of TRSBF is $0.83 and 52 week low is $0.72.
When is next earnings date of 3SBio Inc(TRSBF)?
The next earnings date of 3SBio Inc(TRSBF) is 2025-03-27 Est..
Does 3SBio Inc(TRSBF) pay dividends? If so, how much?
3SBio Inc(TRSBF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers